Permira Acquires Ergomed for $886 Million in Thrilling Pharma Services Takeover
European private equity firm Permira has agreed to acquire British biopharmaceutical services company Ergomed for approximately $886.40 million. The cash offer represents a premium of about 28% to Ergomed's last closing price and has the backing of the board. Ergomed provides clinical research and trial management services and operates globally. This acquisition follows a trend of British healthcare companies being taken private this year. Permira focuses on investments in technology, consumer, healthcare, and services.